Cargando…

Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer

BACKGROUND: Men diagnosed with localized prostate cancer (LPC) can choose from multiple treatment regimens and are faced with a decision in which medical factors and personal preferences are important. The Personal Patient Profile-Prostate (P3P) is a computerized decision aid for men with LPC that f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosco, Jaclyn LF, Halpenny, Barbara, Berry, Donna L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502193/ https://www.ncbi.nlm.nih.gov/pubmed/23021156 http://dx.doi.org/10.1186/1477-7525-10-123

Ejemplares similares

Development and Evaluation of the Personal Patient Profile-Prostate (P3P), a Web-Based Decision Support System for Men Newly Diagnosed With Localized Prostate Cancer
por: Berry, Donna L, et al.
Publicado: (2010)

Usability evaluation and adaptation of the e-health Personal Patient Profile-Prostate decision aid for Spanish-speaking Latino men
por: Berry, Donna L., et al.
Publicado: (2015)

Multidisciplinary Therapy in Men with Newly Diagnosed Oligometastatic Prostate Cancer
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

Men's preferences for prostate cancer screening: a discrete choice experiment
por: de Bekker-Grob, E W, et al.
Publicado: (2013)

Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2021)

Baseline Lower Urinary Tract Symptoms and Sexual Dysfunction in Men with Newly Diagnosed Localized Prostate Cancer
por: Song, Wan, et al.
Publicado: (2023)

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer
por: Reyes, D. K., et al.
Publicado: (2020)

A Pilot Trial of Pembrolizumab plus Prostatic Cryotherapy for Men with Newly Diagnosed Oligometastatic Hormone-Sensitive Prostate Cancer
por: Ross, Ashley E., et al.
Publicado: (2019)

Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions
por: Pozzar, Rachel A., et al.
Publicado: (2022)

Diagnosing hereditary cancer predisposition in men with prostate cancer
por: Pritzlaff, Mary, et al.
Publicado: (2020)

Discordance in perceived risk and epidemiological outcomes of prostate cancer among African American men
por: Rice, LaShanta J., et al.
Publicado: (2017)

Detection of antibodies directed at M. hyorhinis p37 in the serum of men with newly diagnosed prostate cancer
por: Urbanek, Cydney, et al.
Publicado: (2011)

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
por: Yuh, Bertram E., et al.
Publicado: (2019)

Predictors of survival outcomes in native sub Saharan black men newly diagnosed with metastatic prostate cancer
por: Bello, Jibril Oyekunle
Publicado: (2017)

Gene expression panel predicts metastatic‐lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer
por: Rubicz, Rohina, et al.
Publicado: (2016)

Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment
por: de Bekker-Grob, E W, et al.
Publicado: (2013)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of Healium
por: Diefenbach, Michael A, et al.
Publicado: (2023)

Dramatic mixed response of lymphangitic pulmonary metastases in newly diagnosed prostate cancer
por: Gorshein, Elan, et al.
Publicado: (2017)

The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer
por: Parker, Daniel C., et al.
Publicado: (2020)

Health care delivery system contributions to management of newly diagnosed prostate cancer
por: Krampe, Noah, et al.
Publicado: (2023)

Ethnographic investigation of patient–provider communication among African American men newly diagnosed with prostate cancer: a study protocol
por: Palmer, Nynikka R, et al.
Publicado: (2020)

Interobserver agreement of [(68)Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer
por: Derwael, Céline, et al.
Publicado: (2020)

Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries
por: de Freitas, Hayley M., et al.
Publicado: (2019)

Geographic and outcome variation among black men diagnosed with prostate cancer
por: Ragin, Camille, et al.
Publicado: (2011)

The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”
por: Ali, Adnan, et al.
Publicado: (2020)

Discordance between testosterone measurement methods in castrated prostate cancer patients
por: Rouleau, Mélanie, et al.
Publicado: (2019)

Bone Scintigraphy in Staging of Newly Diagnosed Prostate Cancer in Regard of Different Risk Groups
por: Sevcenco, Sabina, et al.
Publicado: (2019)

Health-related quality of life in patients newly diagnosed with prostate cancer: CAPLIFE study
por: Lozano-Lorca, Macarena, et al.
Publicado: (2022)

Is leisure time sitting associated with mortality rates among men diagnosed with localized prostate cancer?
por: Bonn, Stephanie E., et al.
Publicado: (2020)

Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer
por: Reamer, Elyse, et al.
Publicado: (2017)

Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment
por: Uemura, Hiroji, et al.
Publicado: (2016)

Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable Model for Predicting Progression in Men with Newly Diagnosed Prostate Cancer Starting Active Surveillance
por: Light, Alexander, et al.
Publicado: (2022)

Prostate cryoablation combined with androgen deprivation therapy for newly diagnosed metastatic prostate cancer: a propensity score-based study
por: wang, Ning, et al.
Publicado: (2021)

Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative study
por: Chambers, Suzanne K, et al.
Publicado: (2018)

Prostate cancer screening among elderly men in Brazil: should we diagnose or not?
por: Mori, Rafael Ribeiro, et al.
Publicado: (2020)

Men’s preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment
por: Mankowski, Colette, et al.
Publicado: (2016)

Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics
por: Berry, Donna L, et al.
Publicado: (2015)

When to perform bone scintigraphy in patients with newly diagnosed prostate cancer? a retrospective study
por: Lin, Yiwei, et al.
Publicado: (2017)

The cost, survival, and quality‐of‐life implications of guideline‐discordant imaging for prostate cancer
por: Winn, Aaron N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jbs6ji5v2u4c2h1mvlbak6af1e